GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (FRA:OL0) » Definitions » Valuation Rank

Devyser Diagnostics AB (FRA:OL0) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Devyser Diagnostics AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Devyser Diagnostics AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (FRA:OL0) » Definitions » Valuation Rank
Comparable Companies
OSTO:SENZA NGM:LUMITO OSTO:AROC OSTO:IMMNOV XSAT:GEAN OSTO:PROGEN NGM:LEVBIO XSAT:SPERM NGM:ATANA TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA LH
Traded in Other Exchanges
DVYSR:Sweden
Address
Instrumentvagen 19, Hagersten, SWE, 126 53
Website
https://www.devyser.com
Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.